• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Severe weather cited for discontinued manufacturing

Article

PixelOptics will discontinue the atLast! Line of enhanced multifocal lenses, due to winter flood damage at the company?s primary manufacturing site in Thailand, the company announced.

Roanoke, VA-PixelOptics will discontinue the atLast! Line of enhanced multifocal lenses, due to winter flood damage at the company’s primary manufacturing site in Thailand, the company announced. The line was launched worldwide in October 2008.

“It is with deep regret that we have made the decision to discontinue production on our family of atLast! products,” said Brett Craig, PixelOptics president and CEO. “Despite significant efforts to resolve supply issues following floods at our Thailand factory, it has become apparent that production cannot be restored in a timely manner to meet current demand. This decision was not taken lightly and we remain committed to supporting our customers through this period of transition.”

The company’s emPower! Line, manufactured in Japan, is not affected. The company said its U.S. rollout for emPower! is expected to continue and would be followed by a series of European launches throughout the year.

Although the company said the loss of its atLast line is unfortunate, it provides the company the ability to focus its full effort on emPower!

For more articles in this issue of InDispensable, click here.

Related Videos
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.